TY - JOUR T1 - Who is dying from Covid-19 in the United Kingdom? A review of cremation authorisations from a single South Wales’ crematorium JF - medRxiv DO - 10.1101/2020.07.01.20136317 SP - 2020.07.01.20136317 AU - Roland Salmon AU - Stephen Monaghan Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/07/06/2020.07.01.20136317.abstract N2 - Background Covid 19 is pandemic in the UK. To date only studies in the UK on hospital deaths have been published in the peer reviewed literature. Legal requirements for cremation in England and Wales require the collection of information that can be used to improve understanding of Covid 19 deaths in both hospital and community settings.Aim To document demographic and clinical characteristics, including likely place of infection, of individuals dying of Covid 19 to inform public health policyDesign A comprehensive case series of deaths from Covid 19 between 6 April and 30 May.Setting A crematorium in South WalesParticipants Individuals for whom an application was made for cremation.Main outcome measures Age, sex, date and place of death, occupation, comorbidities, where infection acquired.Results Of 752 cremations, 215(28.6%) were Covid-19 of which 115 (53.5%) were male and 100 (46.5%) female. The median age was 82 years, with the youngest patient being 47 years and the oldest 103 years. Over half the deaths (121/215: 56.3%) were over 80 years. Males odds of dying in hospital, rather than the community were 1.96 times that of females (95% Confidence Intervals (CI) 1.03 −3.74, p=0.054) despite being of similar age and having a similar number of comorbidities. Only 21(9.8%) of 215 patients had no comorbidities recorded. Patients dying in nursing homes were significantly older than those dying in hospital(median 88y (IQ range 82-93y) v 80y (IQ range 71-87y): p<0.0001). Patients dying in hospital had significantly more comorbidities than those dying in nursing homes (median 2: IQ range 1-3 v. 1: IQ range 1-2: p <0.001).Conclusions In a representative series, comprising both hospital and community deaths, persons over 80 with an average 2 comorbidities predominated. Although men and women were represented in similar proportions, men were more likely to die in hospital. Over half the infections were acquired in either hospitals or nursing and residential homes with implications for the management of the pandemic, historically and in the future.Competing Interest StatementDr Salmon and Dr Monaghan are Crematorium Medical Referees for the Cardiff Council Crematorium, Thornhill, Cardiff and are remunerated on a fee for service basis.Funding StatementNo dedicated funding has been obtained for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study uses information required under the Cremation (England and Wales) Regulations 2008. Regulation 35 of The Cremation (England and Wales) Regulations 2008 (http://www.legislation.gov.uk/uksi/2008/2841/regulation/35/made) state that: "The register and documents may, with the permission of the cremation authority be open to inspection by any other person and the cremation authority may issue to any person a copy of, or an extract from, the register or a document.” The Council of the City and County of Cardiff, as the cremation authority, has given written consent to use the data observed whilst examining the medical forms for cremation.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data set would, ordinarily, be shared on application to the authors. ER -